Anti-Aβ agents for mild to moderate Alzheimer’s disease: systematic review and meta-analysis
Journal of Neurology, Neurosurgery & Psychiatry
Fecha de publicación: 28 de octubre de 2020
DOI: http://dx.doi.org/10.1136/jnnp-2020-323497
Autores: Liming Lu, Xiaoyan Zheng, Shengwen Wang, Chunzhi Tang, Yuqing Zhang, Gaolei Yao, Jingchun Zeng, Shuqi Ge, Hao Wen, Mingzhu Xu, Gordon Guyatt, Nenggui Xu.
Background: To assess the efficacy and safety of Aβ-targeting agents for mild to moderate Alzheimer’s disease.
